A longtime shortage of a type of sterile intravenous saline is now resolved, the Food and Drug Administration announced Friday.

According to the FDA, sodium chloride 0.9% injection products have been in shortage since 2018. The shortage was exacerbated when Hurricane Helene flooded a Baxter manufacturing plant in Marion, N.C. last fall what was responsible for 60 percent of the IV fluid in the country.

“This marks a significant milestone for public health and reinforces the FDA’s commitment to ensuring Americans have consistent access to life-saving medical products,” FDA Commissioner Marty Makary said in a statement.

Hospitals were left scrambling in the aftermath of Helene, as the shortage of multiple types IV fluid highlighted the fragility and vulnerability of the country’s medical

See Full Page